Baum Douglas R 4
4 · QSAM Biosciences, Inc. · Filed Jun 23, 2023
Insider Transaction Report
Form 4
Baum Douglas R
DirectorCEO & Director
Transactions
- Award
Common Stock
2023-06-23+72,276→ 375,547 total
Holdings
- 684
Series B
- 200
Options to buy common stock
Exercise: $20.00Exp: 2025-01-14→ Common Stock (200 underlying) - 12,500
Options to buy common stock
Exercise: $10.00Exp: 2032-03-03→ Common Stock (12,500 underlying) - 3,125
Options to buy common stock
Exercise: $14.40Exp: 2031-08-23→ Common Stock (3,125 underlying)
Footnotes (5)
- [F1]This award of shares is being made pursuant to the Issuer's restricted stock award agreement and is subject to a vesting schedule, such that a portion or all of this award of restricted stock may be forfeited in the future if certain milestones are not met.
- [F2]Represents shares of Common Stock receivable upon conversion of Series B Preferred Stock at a conversion rate of $5.42 per share, and includes accrued dividends as of 05/31/2023.
- [F3]The option vests annually in two equal installments beginning on 3/3/2023.
- [F4]The option vests annually in two equal installments beginning on 1/14/2021.
- [F5]The option vests semi-annually in two equal installments beginning on 2/24/2022